Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tacrolimus ointment (Protopic) for atopic dermatitis.

J C Pascual1, A B Fleisher

  • 1Department of Dermatology, Hospital General de Alicantem, Alicante, Spain.

Skin Therapy Letter
|November 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-occurrence of Dowling-Degos Disease and Hidradenitis Suppurativa: An Exploratory Study.

Actas dermo-sifiliograficas·2025
Same author

[Translated article] Spanish Hidradenitis Suppurativa Registry (REHS) of the Spanish Academy of Dermatology and Venereology: Description and Data From its First Year of Operation.

Actas dermo-sifiliograficas·2025
Same author

Spanish Hidradenitis Suppurativa Registry (REHS) of the Spanish Academy of Dermatology and Venereology: description and data from its first year of operation.

Actas dermo-sifiliograficas·2025
Same author

Topical and Intralesional Therapies for Hidradenitis Suppurativa: A Systematic Literature Review.

Actas dermo-sifiliograficas·2024
Same author

Topical and Intralesional Therapies for Hidradenitis Suppurativa: A Systematic Literature Review.

Actas dermo-sifiliograficas·2023
Same author

Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.

The British journal of dermatology·2019
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Tacrolimus ointment is a safe and effective topical immunomodulator for atopic dermatitis (AD). It works by inhibiting calcineurin, offering a non-corticosteroid option without causing skin thinning.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin condition.
  • Topical corticosteroids are common treatments but have side effects.
  • A need exists for safe and effective long-term AD therapies.

Purpose of the Study:

  • To evaluate the efficacy and safety of tacrolimus ointment for atopic dermatitis.
  • To compare tacrolimus ointment with topical corticosteroids.

Main Methods:

  • Tacrolimus ointment, a topical immunomodulator, was studied.
  • Mechanism involves calcineurin inhibition, reducing T-cell activation and cytokine release.

Main Results:

  • Tacrolimus ointment demonstrated safety and efficacy in short- and long-term AD treatment for pediatric and adult patients.

Related Experiment Videos

  • Common side effects included transient burning and pruritus.
  • Unlike corticosteroids, it did not cause skin thinning or reduced collagen synthesis.

    • Conclusions:

    • Tacrolimus ointment is a safe and effective treatment for atopic dermatitis.
    • Its non-atrophying properties allow for extended use on all skin areas, including sensitive regions.